All In Biotech

Drug Trial Radar · NCT02942160

EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)

A Phase 2, Open-Label Extension Study of EN3835 in the Treatment of Edematous Fibrosclerotic Panniculopathy

Last checked: Nov 19, 2026Latest source record: Nov 24, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

259

Actual

Start

Oct 5, 2016

Primary completion

Jun 14, 2018

Study completion Jun 14, 2018

Sponsor

Sponsor type
Industry
First posted
Oct 21, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A Phase 2, Open-Label Extension Study of EN3835 in the Treatment of Edematous Fibrosclerotic Panniculopathy (commonly known as Cellulite).

Conditions

  • Edematous Fibrosclerotic Panniculopathy
  • Cellulite

Interventions

  • Collagenase Clostridium HistolyticumBiological

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants That Were 2-level Composite (CR-PCSS and PR-PCSS) Responders During the Observation PhaseTime frame: Day 180 to Day 360

Locations

15 sites in 1 country. Site status is shown where the registry gives one.

  • Endo Clinical Trial Site #1

    Beverly Hills, California

  • Endo Clinical Trial Site #2

    Murrieta, California

  • Endo Clinical Trial Site #3

    Oceanside, California

  • Endo Clinical Trial Site #4

    San Diego, California

  • Endo Clinical Trial Site #5

    Clearwater, Florida

  • Endo Clinical Trial Site #6

    Coral Gables, Florida

  • Endo Clinical Trial Site #7

    Palm Beach, Florida

  • Endo Clinical Trial Site #8

    Washington, Missouri

  • Endo Clinical Trial Site #10

    New York, New York

  • Endo Clinical Trial Site #9

    New York, New York

  • Endo Clinical Trial Site #11

    Nashville, Tennessee

  • Endo Clinical Trial Site #12

    Pflugerville, Texas

  • Endo Clinical Trial Site #13

    Charlottesville, Virginia

  • Endo Clinical Trial Site #14

    Lynchburg, Virginia

  • Endo Clinical Trial Site #15

    Spokane, Washington

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.